Sunshine Biopharma Warrant Stock Current Valuation
| SBFMW Stock | USD 0.1 0.01 6.59% |
Valuation analysis of Sunshine Biopharma helps investors to measure Sunshine Biopharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -146.07 in 2024. Enterprise Value Multiple is likely to drop to -146.07 in 2024.
Fairly Valued
Today
Please note that Sunshine Biopharma's price fluctuation is out of control at this time. Calculation of the real value of Sunshine Biopharma is based on 3 months time horizon. Increasing Sunshine Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Sunshine Biopharma Warrant is useful when determining the fair value of the Sunshine stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Sunshine Biopharma. Since Sunshine Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sunshine Stock. However, Sunshine Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0971 | Real 0.0897 | Hype 0.09 | Naive 0.0942 |
The real value of Sunshine Stock, also known as its intrinsic value, is the underlying worth of Sunshine Biopharma Company, which is reflected in its stock price. It is based on Sunshine Biopharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Sunshine Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sunshine Biopharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sunshine Biopharma Warrant helps investors to forecast how Sunshine stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sunshine Biopharma more accurately as focusing exclusively on Sunshine Biopharma's fundamentals will not take into account other important factors: Sunshine Biopharma Warrant Company Current Valuation Analysis
Sunshine Biopharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Sunshine Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Sunshine Biopharma is extremely important. It helps to project a fair market value of Sunshine Stock properly, considering its historical fundamentals such as Current Valuation. Since Sunshine Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sunshine Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sunshine Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
Sunshine Current Valuation Historical Pattern
Today, most investors in Sunshine Biopharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sunshine Biopharma's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sunshine Biopharma current valuation as a starting point in their analysis.
Sunshine Biopharma Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sunshine Biopharma Warrant has a Current Valuation of 0.0. This is 100.0% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 0.0) industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Sunshine Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sunshine Biopharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sunshine Biopharma could also be used in its relative valuation, which is a method of valuing Sunshine Biopharma by comparing valuation metrics of similar companies.Sunshine Biopharma is currently under evaluation in current valuation category among related companies.
Sunshine Fundamentals
| Return On Equity | -0.21 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.15) % | ||||
| Number Of Shares Shorted | 8.22 K | ||||
| Revenue | 24.09 M | ||||
| Gross Profit | 110.6 K | ||||
| EBITDA | (4.64 M) | ||||
| Net Income | (4.51 M) | ||||
| Cash And Equivalents | 40.56 M | ||||
| Cash Per Share | 1.80 X | ||||
| Total Debt | 657.71 K | ||||
| Debt To Equity | 8.98 % | ||||
| Current Ratio | 85.09 X | ||||
| Book Value Per Share | 75.67 X | ||||
| Cash Flow From Operations | (8.78 M) | ||||
| Earnings Per Share | (2.21) X | ||||
| Number Of Employees | 44 | ||||
| Beta | -0.78 | ||||
| Total Asset | 27.35 M | ||||
| Retained Earnings | (63.91 M) | ||||
| Working Capital | 19.34 M | ||||
| Net Asset | 27.35 M |
About Sunshine Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunshine Biopharma Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunshine Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunshine Biopharma Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sunshine Biopharma is a strong investment it is important to analyze Sunshine Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sunshine Biopharma's future performance. For an informed investment choice regarding Sunshine Stock, refer to the following important reports:Check out Sunshine Biopharma Piotroski F Score and Sunshine Biopharma Altman Z Score analysis. For more information on how to buy Sunshine Stock please use our How to Invest in Sunshine Biopharma guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Sunshine Stock analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Sunshine Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.21) | Revenue Per Share 99.017 | Quarterly Revenue Growth 0.949 | Return On Assets (0.11) | Return On Equity (0.21) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.